First Trust Direct Indexing’s Intuitive Surgical ISRG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-13,483
Closed -$6.62M 447
2024
Q3
$6.62M Buy
13,483
+1,066
+9% +$496K 0.36% 45
2024
Q2
$5.52M Buy
12,417
+2,129
+21% +$848K 0.34% 47
2024
Q1
$4.11M Buy
10,288
+669
+7% +$253K 0.31% 60
2023
Q4
$3.25M Buy
9,619
+418
+5% +$125K 0.29% 60
2023
Q3
$2.69M Sell
9,201
-233
-2% -$72.8K 0.31% 55
2023
Q2
$3.23M Sell
9,434
-127
-1% -$38.4K 0.36% 46
2023
Q1
$2.44M Sell
9,561
-86
-0.9% -$21.2K 0.29% 65
2022
Q4
$2.56M Buy
9,647
+371
+4% +$90.5K 0.34% 52
2022
Q3
$1.74M Buy
9,276
+481
+5% +$103K 0.25% 85
2022
Q2
$1.76M Buy
8,795
+390
+5% +$91.5K 0.25% 89
2022
Q1
$2.54M Buy
8,405
+838
+11% +$245K 0.31% 59
2021
Q4
$2.72M Buy
7,567
+157
+2% +$54K 0.35% 49
2021
Q3
$2.46M Buy
7,410
+621
+9% +$209K 0.35% 48
2021
Q2
$2.08M Buy
6,789
+2,691
+66% +$755K 0.31% 61
2021
Q1
$1.01M Buy
4,098
+240
+6% +$60.4K 0.27% 93
2020
Q4
$1.05M Buy
+3,858
New +$958K 0.28% 74

Other funds holding ISRG

First Trust Direct Indexing's ISRG Position: Q4 2024 in Review

First Trust Direct Indexing sold out of Intuitive Surgical (ISRG) in Q4 2024, closing a stake of 13,483 shares — an estimated $6.62M sold.

First Trust Direct Indexing first reported a position in ISRG in Q4 2020 and held it in 16 quarters. The position peaked at $6.62M in Q3 2024. 2,129 funds tracked by Wall St. Rank hold ISRG as of Q4 2024.

  • First Trust Direct Indexing reported no remaining Intuitive Surgical position as of Q4 2024 after selling out during the quarter.
  • First Trust Direct Indexing sold 13,483 Intuitive Surgical shares in Q4 2024, an estimated $6.62M.
  • First Trust Direct Indexing first reported a position in Intuitive Surgical in Q4 2020 and held it in 16 quarters.
  • First Trust Direct Indexing's Intuitive Surgical position peaked at $6.62M in Q3 2024.
  • 2,129 funds tracked by Wall St. Rank held Intuitive Surgical as of Q4 2024.

Based on First Trust Direct Indexing's 13F filing for Q4 2024.